SG11201403437TA - Ion exchange membrane chromatography - Google Patents

Ion exchange membrane chromatography

Info

Publication number
SG11201403437TA
SG11201403437TA SG11201403437TA SG11201403437TA SG11201403437TA SG 11201403437T A SG11201403437T A SG 11201403437TA SG 11201403437T A SG11201403437T A SG 11201403437TA SG 11201403437T A SG11201403437T A SG 11201403437TA SG 11201403437T A SG11201403437T A SG 11201403437TA
Authority
SG
Singapore
Prior art keywords
ion exchange
exchange membrane
membrane chromatography
chromatography
ion
Prior art date
Application number
SG11201403437TA
Other languages
English (en)
Inventor
Jerome Joseph Bill Jr
Arick Michael Brown
Christopher John Dowd
Brooke Ellen Thayer
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47430154&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201403437T(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of SG11201403437TA publication Critical patent/SG11201403437TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG11201403437TA 2011-12-22 2012-12-18 Ion exchange membrane chromatography SG11201403437TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161579285P 2011-12-22 2011-12-22
PCT/US2012/070373 WO2013096322A1 (fr) 2011-12-22 2012-12-18 Chromatographie sur membrane échangeuse d'ions

Publications (1)

Publication Number Publication Date
SG11201403437TA true SG11201403437TA (en) 2014-07-30

Family

ID=47430154

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201403437TA SG11201403437TA (en) 2011-12-22 2012-12-18 Ion exchange membrane chromatography

Country Status (22)

Country Link
US (2) US10364268B2 (fr)
EP (2) EP3492486A1 (fr)
JP (5) JP6605202B2 (fr)
KR (3) KR20210025692A (fr)
CN (2) CN108892706A (fr)
AR (1) AR089362A1 (fr)
AU (3) AU2012355356B2 (fr)
BR (1) BR112014015101A8 (fr)
CA (1) CA2859376C (fr)
ES (1) ES2697676T3 (fr)
HK (1) HK1203526A1 (fr)
HR (1) HRP20181846T1 (fr)
IL (2) IL267585B (fr)
MX (2) MX360453B (fr)
MY (1) MY172426A (fr)
PL (1) PL2794635T3 (fr)
RU (1) RU2648999C2 (fr)
SG (1) SG11201403437TA (fr)
SI (1) SI2794635T1 (fr)
TR (1) TR201815709T4 (fr)
WO (1) WO2013096322A1 (fr)
ZA (2) ZA201404593B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012355356B2 (en) 2011-12-22 2017-10-12 Genentech, Inc. Ion exchange membrane chromatography
KR101975771B1 (ko) 2013-12-12 2019-05-09 이엠디 밀리포어 코포레이션 아크릴아미드 함유 필터를 사용한 단백질 분리
MX2016008498A (es) 2013-12-27 2016-10-07 Chugai Pharmaceutical Co Ltd Metodo para purificar anticuerpo que tiene bajo punto isoelectrico.
CN104693303B (zh) * 2015-02-28 2018-03-13 苏州金盟生物技术有限公司 一种蛋白制品中的核酸去除方法
PT3334747T (pt) 2015-08-13 2023-12-12 Amgen Inc Formulação de gonadotrofina líquida estável
GB201711481D0 (en) 2017-07-17 2017-08-30 Ucb Biopharma Sprl Protein purification
EP3546475A1 (fr) * 2018-03-27 2019-10-02 Sanofi Processus d'écoulement intégral pour purifier des protéines recombinées
US10792618B2 (en) 2018-06-19 2020-10-06 Sartorius Stedim Biotech Gmbh Particle separation and/or purification of a fluid
GB201815405D0 (en) * 2018-09-21 2018-11-07 Fujifilm Mfg Europe Bv Membranes suitable for detecting, filtering and/or purifying biomolecules
US20210396725A1 (en) * 2018-12-21 2021-12-23 3M Innovative Properties Company Method for Testing a Chromatography Device Used for Ion Exchange
TW202112799A (zh) * 2019-06-05 2021-04-01 美商建南德克公司 過載層析管柱之再生方法
US11416468B2 (en) * 2020-07-21 2022-08-16 International Business Machines Corporation Active-active system index management
CN116371011B (zh) * 2023-05-26 2023-08-18 湖南杰萃生物技术有限公司 一种从桑叶中提取黄酮和生物碱的方法
CN117866038B (zh) * 2024-03-11 2024-05-28 北京百力格生物科技有限公司 纯化含有宿主核酸的带亲和标签的酸性蛋白的方法

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE266710C (fr)
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
JPS6150925A (ja) * 1984-08-17 1986-03-13 Toray Ind Inc 抗原または抗体の精製方法
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US5091178A (en) 1986-02-21 1992-02-25 Oncogen Tumor therapy with biologically active anti-tumor antibodies
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
WO1989003840A1 (fr) * 1987-10-23 1989-05-05 Schering Corporation Procede de purification de proteines
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
JP2749167B2 (ja) 1988-06-21 1998-05-13 ジェネンテク，インコーポレイテッド 心筋梗塞の処置のための方法および治療用組成物
DE68925971T2 (de) 1988-09-23 1996-09-05 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
JP2844346B2 (ja) * 1989-05-31 1999-01-06 昭 梶 新規ペプチドならびに新規ｄｎａ
EP0402226A1 (fr) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Vecteurs de transformation de la levure yarrowia
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
JP3457962B2 (ja) 1991-08-14 2003-10-20 ジェネンテク，インコーポレイテッド 特定Ｆｃεレセプターのための免疫グロブリン変異体
DK1136556T3 (da) 1991-11-25 2005-10-03 Enzon Inc Fremgangsmåde til fremstilling af multivalente antigen-bindende proteiner
AU675929B2 (en) 1992-02-06 1997-02-27 Curis, Inc. Biosynthetic binding protein for cancer marker
DE69315847T2 (de) 1992-08-21 1998-06-25 Genentech Inc Verfahren zur behandlung einer durch lfa-1 vermittelten störung
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5595721A (en) 1993-09-16 1997-01-21 Coulter Pharmaceutical, Inc. Radioimmunotherapy of lymphoma using anti-CD20
RU2145873C1 (ru) 1993-09-21 2000-02-27 Хемосол Инк. Способ очистки гемоглобина в коммерческом масштабе
ES2108566T3 (es) 1993-12-10 1997-12-16 Genentech Inc Procedimientos para diagnosticar alergias y para seleccionar agentes terapeuticos antialergicos.
JP3825798B2 (ja) 1994-01-18 2006-09-27 ジェネンテク，インコーポレイテッド ＩｇＥアンタゴニストを用いる寄生虫感染症の治療法
EP0749488A1 (fr) 1994-03-03 1996-12-27 Genentech, Inc. Anticorps monoclonaux anti-il-8 pour le traitement des troubles
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
AU6267896A (en) 1995-06-07 1996-12-30 Imclone Systems Incorporated Antibody and antibody fragments for inhibiting the growth oftumors
DK0877626T3 (da) 1996-01-23 2002-12-30 Univ Vermont Anti-CD18 antistoffer til anvendelse mod slagtilfælde
AU1458497A (en) * 1996-01-31 1997-08-22 John Stephen Ayers Production of an immunoglobulin enriched fraction from whey protein solutions
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
WO1998023761A1 (fr) 1996-11-27 1998-06-04 Genentech, Inc. ANTICORPS ANTI-CD11a HUMANISES
EP1325932B9 (fr) 1997-04-07 2006-07-19 Genentech, Inc. Anticorps anti-VEGF
CA2287911C (fr) 1997-05-15 2014-05-06 Genentech, Inc. Recepteur d'apo-2
US6054293A (en) 1997-07-08 2000-04-25 The Regents Of The University Of California Semaphorin receptors
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
AU784045B2 (en) 1999-06-25 2006-01-19 Genentech Inc. Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
CN1413220A (zh) 1999-10-29 2003-04-23 杰南技术公司 抗前列腺干细胞抗原(psca)抗体组合物及其应用方法
NZ523831A (en) * 2000-07-13 2005-10-28 Invitrogen Corp Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix
UA83458C2 (uk) 2000-09-18 2008-07-25 Байоджен Айдек Ма Інк. Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
US7321026B2 (en) 2001-06-27 2008-01-22 Skytech Technology Limited Framework-patched immunoglobulins
CA2460819A1 (fr) 2001-09-18 2003-03-27 Affinium Pharmaceuticals, Inc. Procedes et appareils de purification
WO2003033656A2 (fr) 2001-10-16 2003-04-24 Exelixis, Inc. Proteines msrebp utilisees comme modificateurs de la voie srebp et leurs methodes d'utilisation
WO2003033658A2 (fr) 2001-10-17 2003-04-24 Human Genome Sciences, Inc. Neutrokine-alpha et variant d'epissage de neutrokine-alpha
US20040093621A1 (en) 2001-12-25 2004-05-13 Kyowa Hakko Kogyo Co., Ltd Antibody composition which specifically binds to CD20
EP1519959B1 (fr) 2002-02-14 2014-04-02 Immunomedics, Inc. Anticorps anti-cd20 et proteines hybrides desdits anticorps, et methodes d'utilisation
WO2004035607A2 (fr) 2002-10-17 2004-04-29 Genmab A/S Anticorps monoclonaux humains anti-cd20
BRPI0316779B1 (pt) 2002-12-16 2020-04-28 Genentech Inc anticorpo humanizado que liga cd20 humano, composição, artigo manufaturado, método de indução da apoptose, método de tratamento de câncer cd20 positivo, métodos de tratamento de doenças autoimunes, ácidos nucléicos isolados, vetores de expressão, células hospedeiras, método para a produção de um anticorpo 2h7 humanizado, polipeptídeo isolado, formulação líquida, método de tratamento de artrite reumatóide (ra) e anticorpos de ligação de cd20 humanizados
CN1206240C (zh) * 2003-04-07 2005-06-15 中国科学院生态环境研究中心 高效离子交换膜色谱纯化卵黄蛋白原技术
KR101412271B1 (ko) 2003-05-09 2014-06-25 듀크 유니버시티 Ｃｄ２０-특이적 항체 및 이를 이용한 방법
AR044388A1 (es) 2003-05-20 2005-09-07 Applied Molecular Evolution Moleculas de union a cd20
JP4818917B2 (ja) 2003-08-08 2011-11-16 イミューノメディクス、インコーポレイテッド 腫瘍および罹患細胞のアポトーシスを誘発するための二重特異性抗体
US8147832B2 (en) 2003-08-14 2012-04-03 Merck Patent Gmbh CD20-binding polypeptide compositions and methods
US20080274501A1 (en) * 2007-05-02 2008-11-06 Chenming Zhang Method of purifying acidic proteins expressed in plants
US9433922B2 (en) 2007-08-14 2016-09-06 Emd Millipore Corporation Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
JP5778389B2 (ja) 2007-10-26 2015-09-16 旭化成ケミカルズ株式会社 たんぱく質の精製方法
SG175597A1 (en) 2007-10-30 2011-11-28 Genentech Inc Antibody purification by cation exchange chromatography
WO2009135656A1 (fr) * 2008-05-06 2009-11-12 Lonza Biologics Plc. Procédé de purification d’anticorps à l’aide de la chromatographie de déplacement
ES2527943T5 (es) * 2008-08-14 2019-03-07 Genentech Inc Métodos para eliminar un contaminante usando cromatografía de membrana de intercambio iónico de desplazamiento de proteínas
GB0816242D0 (en) 2008-09-05 2008-10-15 Immunobiology Ltd Method of purifying protien complexes
KR20190018041A (ko) 2009-08-06 2019-02-20 제넨테크, 인크. 단백질 정제 시의 바이러스 제거의 개선방법
MX2012002565A (es) 2009-09-01 2012-05-29 Genentech Inc Purificacion de proteina mejorada a traves de una elucion de proteina a modificada.
TWI586806B (zh) * 2010-04-23 2017-06-11 建南德克公司 異多聚體蛋白質之製造
NZ603648A (en) 2010-05-25 2014-12-24 Genentech Inc Methods of purifying polypeptides
JP2014534421A (ja) * 2011-10-03 2014-12-18 サッチェム，インコーポレイテッド 疎水性置換クロマトグラフィーのための中性双性イオン性置換剤分子
AU2012355356B2 (en) 2011-12-22 2017-10-12 Genentech, Inc. Ion exchange membrane chromatography
US9813410B2 (en) 2014-06-26 2017-11-07 Rakuten, Inc. Information processing apparatus, information processing method, and information processing program

Also Published As

Publication number Publication date
EP2794635A1 (fr) 2014-10-29
IL267585A (en) 2019-08-29
CN104125963B (zh) 2018-08-17
US10364268B2 (en) 2019-07-30
KR20200008022A (ko) 2020-01-22
MX2014007622A (es) 2014-09-22
MY172426A (en) 2019-11-25
AU2020201070A1 (en) 2020-03-05
US20200102346A1 (en) 2020-04-02
AU2012355356B2 (en) 2017-10-12
RU2648999C2 (ru) 2018-03-29
CA2859376A1 (fr) 2013-06-27
NZ626949A (en) 2016-11-25
AR089362A1 (es) 2014-08-20
CN104125963A (zh) 2014-10-29
US11945837B2 (en) 2024-04-02
AU2018200194B2 (en) 2019-11-14
JP2015503524A (ja) 2015-02-02
JP7402011B2 (ja) 2023-12-20
HK1203526A1 (en) 2015-10-30
BR112014015101A2 (pt) 2017-06-13
RU2014130017A (ru) 2016-02-10
JP2021169454A (ja) 2021-10-28
IL267585B (en) 2022-09-01
WO2013096322A1 (fr) 2013-06-27
MX2018013356A (es) 2020-09-14
WO2013096322A8 (fr) 2018-09-13
KR20210025692A (ko) 2021-03-09
EP2794635B8 (fr) 2018-11-14
ES2697676T3 (es) 2019-01-25
AU2012355356A1 (en) 2014-07-10
IL233158A0 (en) 2014-07-31
JP6605202B2 (ja) 2019-11-13
IL233158B (en) 2019-07-31
JP2022101557A (ja) 2022-07-06
KR20140114834A (ko) 2014-09-29
US20140348845A1 (en) 2014-11-27
WO2013096322A9 (fr) 2013-08-22
CN108892706A (zh) 2018-11-27
JP2020040952A (ja) 2020-03-19
SI2794635T1 (sl) 2018-12-31
ZA201404593B (en) 2022-12-21
HRP20181846T1 (hr) 2018-12-28
EP2794635B1 (fr) 2018-09-12
EP3492486A1 (fr) 2019-06-05
PL2794635T3 (pl) 2019-02-28
ZA201903994B (en) 2023-12-20
BR112014015101A8 (pt) 2021-06-08
JP7359807B2 (ja) 2023-10-11
CA2859376C (fr) 2022-04-19
MX360453B (es) 2018-11-01
AU2018200194A1 (en) 2018-02-01
TR201815709T4 (tr) 2018-11-21
JP2018109024A (ja) 2018-07-12
KR102067075B1 (ko) 2020-01-17

Similar Documents

Publication Publication Date Title
IL267585A (en) Ion exchange membrane chromatography
EP2798691A4 (fr) Humidificateur à membrane
EP2692782A4 (fr) Membrane échangeuse d'ions
EP2714250A4 (fr) Membranes
HK1217232A1 (zh) 離子强度介導的 梯度離子交換色譜
PL2734473T3 (pl) Związki typu granatu przewodzące jony litu
EP2667919A4 (fr) Humidificateur
GB201107849D0 (en) Cooperative positioning
HK1214938A1 (zh) 分析輔件
IL238131B (en) Coated membranes for ion exchange
EP2698839A4 (fr) Bloc de cellules
IL225720A0 (en) Antibody purification in one ion exchange chromatography unit
EP2665057A4 (fr) Système de spectacle
EP2711340A4 (fr) Équipement échangeur d'ions
EP2800229A4 (fr) Système de pile
EP2709203A4 (fr) Système cellulaire
EP2734659A4 (fr) Support de membranes échangeuses d'ions
GB201118288D0 (en) Ion-conducting membrane
SG11201501151TA (en) Methods for manufacturing ion exchange membranes
GB201109281D0 (en) Membrane
GB2494304B (en) Spacer
SG11201400765SA (en) Electrochemical processor alignment system
GB2499313B (en) Ion exchange
ZA201102777B (en) Spacer
GB201120948D0 (en) Flooring membrane